Ehrlich Christopher B
Related Filers (34)
- eFFECTOR Therapeutics, Inc. (13)
- BIOMIMETIC THERAPEUTICS, INC. (9)
- Transcept Pharmaceuticals Inc (9)
- GIANOS PHILIP T (8)
- INTERWEST INVESTORS VIII L P (7)
- INTERWEST PARTNERS VIII LP (7)
- INTERWEST INVESTORS Q VIII LP (7)
- Pepper Douglas A (7)
- InterWest Management Partners VIII, LLC (6)
- Bowsher Stephen C (6)
- Holmes W Stephen (6)
- Rosch Thomas L (5)
- Kjellson Nina S (5)
- NASR KHALED (5)
- Grais Linda S (5)
- CASH HARVEY B (5)
- Nash H Ronald (5)
- ANESIVA, INC. (4)
- INTRALASE CORP (3)
- ORONSKY ARNOLD L (3)
- Adler John C (3)
- EnteroMedics Inc (3)
- InterWest Management Partners IX, LLC (3)
- Westerlind Victor A (3)
- HEDRICK W SCOTT (3)
- Kliman Gilbert H (3)
- CERO THERAPEUTICS HOLDINGS, INC. (3)
- InterWest Partners IX, LP (2)
- Trius Therapeutics Inc (2)
- INTERWEST PARTNERS X LP (2)
- CLEVELAND BRUCE A (2)
- TESARO, Inc. (2)
- MYOGEN INC (1)
- SWEENEY MICHAEL B (1)
- Show More ...
Ownership (49)
4
Friday, 2/16/2024
CERO THERAPEUTICS HOLDINGS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/27/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/10/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/7/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/12/2021
PHOENIX BIOTECH ACQUISITION CORP.: Statement of changes in beneficial ownership of securities
4
Friday, 10/8/2021
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/5/2021
PHOENIX BIOTECH ACQUISITION CORP.: Initial statement of beneficial ownership of securities
4
Friday, 8/27/2021
eFFECTOR Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/14/2021
Locust Walk Acquisition Corp.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/7/2021
Locust Walk Acquisition Corp.: Initial statement of beneficial ownership of securities
4
Thursday, 4/11/2013
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/5/2013
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/8/2013
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 7/5/2012
TESARO, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/27/2012
TESARO, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/25/2012
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 9/22/2011
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2011
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/10/2010
Trius Therapeutics Inc: Statement of changes in beneficial ownership of securities
3
Monday, 8/2/2010
Trius Therapeutics Inc: Initial statement of beneficial ownership of securities
4
Thursday, 2/4/2010
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2010
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/8/2009
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/3/2009
Transcept Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
4
Tuesday, 2/3/2009
Transcept Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4/A
Monday, 6/23/2008
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/20/2008
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 6/13/2008
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/20/2007
ANESIVA, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/21/2007
EnteroMedics Inc: Statement of changes in beneficial ownership of securities
4
Monday, 11/19/2007
EnteroMedics Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/14/2007
EnteroMedics Inc: Initial statement of beneficial ownership of securities
4
Monday, 6/25/2007
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/16/2006
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 5/15/2006
BIOMIMETIC THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/10/2006
BIOMIMETIC THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
3/A
Friday, 3/31/2006
CORGENTECH INC: Initial statement of beneficial ownership of securities
4
Wednesday, 3/1/2006
CORGENTECH INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 12/21/2005
CORGENTECH INC: Initial statement of beneficial ownership of securities
4
Thursday, 6/30/2005
MYOGEN INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2005
INTRALASE CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/13/2004
INTRALASE CORP: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/6/2004
INTRALASE CORP: Initial statement of beneficial ownership of securities